2026 NPPES data Family Nurse Practitioner NPI 1619515293
Verify on CMS →

Lanigail Pangilinan

Family Nurse Practitioner in Fresno, California.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 209,817 in Family Nurse Practitioner, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
809
Medicare Part D claims · 149 beneficiaries · Family Nurse Practitioner avg: 1K
Generic prescribing
46%
generic claims · 54% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$166.07
3 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Lanigail Pangilinan filed 809 Medicare Part D claims in 2023 as a Family Nurse Practitioner in Fresno, California, prescribing 46% generic.

809
Part D claims, 2023
46%
generic prescribing
$166.07
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Lanigail Pangilinan's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

809 Top 27% higher than 73% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about Lanigail Pangilinan?

Quality data not reported

NPI registry status

Active

Issued 12/14/2019

NPI 1619515293

Primary specialty

Family Nurse Practitioner

High-volume

209,817 US NPIs in this specialty

Medicare Part D claims

809 34% vs specialty avg

2023 prescription claims

Specialty avg: 1,222

Specialty distribution in California

How Family Nurse Practitioner compares to other specialties among California providers

California providers
Behavior Technician - 17.3%Behavior Technician17.3%Marriage & Family Therapist - 5.5%Marriage & Family Therapist5.5%Student in an Organized Health Care Education/Training Program - 5%Student in an Organized Health Care Education/Training Program5%Mental Health Counselor - 3.9%Mental Health Counselor3.9%Pharmacist - 3.5%Pharmacist3.5%Clinical Social Worker - 3.1%Clinical Social Worker3.1%Family Nurse Practitioner - 1.6%Family Nurse Practitioner1.6%
Largest specialties in California (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Family Nurse Practitioner. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Lanigail Pangilinan appears in the CMS NPPES registry as a Family Nurse Practitioner provider at 2610 E NEES AVE APT 109, Fresno, CA, 93720, with a listed phone of (323) 382-5160. NPI 1619515293 was issued on 12/14/2019.

Medicare Part D records for calendar year 2023 show 809 prescription claims written by this provider, covering 149 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 54% brand-name and 46% generic by claim count.

Family Nurse Practitioner is a high-volume specialty nationwide, with 209,817 enrolled providers across 56 states and an average of 1,222 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2610 E NEES AVE APT 109
Fresno, CA 93720

Provider Details

NPI 1619515293
Specialty Family Nurse Practitioner
Gender Female
NPI Issued 12/14/2019

Hospital and facility affiliations

Facilities where Lanigail Pangilinan bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

The Nephrology Group Inc
Fresno, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Lanigail Pangilinan. Source: openpaymentsdata.cms.gov.

Total received

$166

Largest payer

Fresenius USA Marketing, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - California MBC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Lanigail Pangilinan. To verify Lanigail Pangilinan's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Lanigail Pangilinan - brand share 54.0%
Family Nurse Practitioner average

54% brand-name claims vs 46% generic, on 809 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

809
Total Claims
$1.1M
Total Drug Cost
149
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,065
Total Day Supply
30,466
Brand vs Generic
54% brand / 46% generic
Brand Drug Cost
$1.0M
Generic Drug Cost
$115K

Patient Demographics

Average Patient Age
62.8 years
Avg HCC Risk Score
9.23
Gender Split
41% female / 59% male
Age Distribution
<65: 73, 65-74: 47, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Lanigail Pangilinan prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Sevelamer Carbonate
274
Velphoro
Sucroferric Oxyhydroxide
225
Renvela
Sevelamer Carbonate
61
Calcium Acetate
58
Veltassa
Patiromer Calcium Sorbitex
36
Clinolipid
Fat Emulsion/Olive/Soy/Phospho
33
Prosol
Parenteral Amino Acid 20% No.1
27
Lanthanum Carbonate
25
Hydralazine Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Family Nurse Practitioner Overview

How Lanigail Pangilinan fits within the Family Nurse Practitioner landscape nationally.

209,817
Family Nurse Practitioner Providers in US
56
States with Family Nurse Practitioner
1,222
Avg Claims per Provider

Lanigail Pangilinan's 809 claims are below the specialty average of 1,222.

Nearby Family Nurse Practitioner Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Pangilinan.

Compare Family Nurse Practitioner nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Family Nurse Practitioner peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Lanigail Pangilinan's specialty?
Lanigail Pangilinan specializes in Family Nurse Practitioner and practices in Fresno, California.
How much does Lanigail Pangilinan prescribe under Medicare Part D?
In 2023, Lanigail Pangilinan wrote 809 Medicare Part D claims totaling $1.1M in drug costs for 149 beneficiaries.
Where is Lanigail Pangilinan located?
Lanigail Pangilinan is located at 2610 E NEES AVE APT 109, Fresno, CA, 93720. Phone: (323) 382-5160.
What is Lanigail Pangilinan's NPI number?
Lanigail Pangilinan's National Provider Identifier (NPI) is 1619515293, issued on 12/14/2019.
Does Lanigail Pangilinan prescribe more brand-name or generic drugs?
Lanigail Pangilinan's prescribing is 54% brand-name and 46% generic drugs by claim count, with $1.0M in brand drug costs.
How many Family Nurse Practitioner providers are there in the US?
There are 209,817 Family Nurse Practitioner providers across 56 states in the US. The average Family Nurse Practitioner provider writes 1,222 Medicare Part D claims per year.
What drugs does Lanigail Pangilinan prescribe most often?
Based on 2023 Medicare Part D data, Lanigail Pangilinan's most frequently prescribed drugs include Sevelamer Carbonate, Velphoro, Renvela. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Lanigail Pangilinan accept Medicare?
Lanigail Pangilinan appears in CMS Medicare data with 809 Part D claims and 149 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Lanigail Pangilinan's credentials?
Lanigail Pangilinan's NPI is 1619515293. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.